Non-communicable diseases (NCDs), including cancer, are the most common cause of death and disability worldwide, accounting for 70% of all deaths. Despite recent improvements in the provision of cancer care worldwide, access to surgery, radiotherapy, essential oncology medicines, and specialized human resources remains an enormous challenge. This is particularly the case in low- and middle-income countries (LMICs), which now face the largest NCD burden but are least equipped to respond. Worldwide, 800 million people are spending at least 10% of their household budget on out-of-pocket health care expenses, and nearly 100 million people are being pushed into extreme poverty each year due to health care costs.
Takeda’s partnership with City Cancer Challenge will support 10 global cities to deliver sustainable, equitable access to quality cancer care. Bringing together city stakeholders from a diverse range of sectors, each city will be engaged in the design, planning, and implementation of cancer care solutions. The program will ensure that patients have access to the high-quality cancer care they need and deserve without being exposed to financial hardship. In the long term, these efforts will result in stronger health systems while catalyzing investment in cancer and NCDs, which, in turn, will help drive progress towards the global target of reducing premature deaths from NCDs, including cancer.
Partner: City Cancer Challenge
Budget: 1 billion yen
Term: 5 years
Global Access Program for the Most Neglected Patients
Transforming the Lives of Children with Serious Illness, and Their Families
Immunization and Universal Health Coverage
Investment in Innovation and Frontier Technology